Form 8-K - Current report:
SEC Accession No. 0001104659-25-063287
Filing Date
2025-06-27
Accepted
2025-06-27 07:30:39
Documents
13
Period of Report
2025-06-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2519194d1_8k.htm   iXBRL 8-K 47588
2 EXHIBIT 10.1 tm2519194d1_ex10-1.htm EX-10.1 126414
  Complete submission text file 0001104659-25-063287.txt   372247

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA uthr-20250626.xsd EX-101.SCH 3011
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE uthr-20250626_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE uthr-20250626_pre.xml EX-101.PRE 22356
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2519194d1_8k_htm.xml XML 3574
Mailing Address 1000 SPRING ST SILVER SPRING MD 20910
Business Address 1000 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

EIN.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26301 | Film No.: 251082225
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)